Richard Scolyer Faces Terminal Prognosis as Brain Cancer Returns
The former Australian of the Year reveals his glioblastoma has regrown, leaving him with months to live despite groundbreaking treatment efforts.
- Richard Scolyer, a renowned pathologist and former Australian of the Year, announced his brain cancer has returned and is terminal, with doctors estimating he has only months to live.
- Scolyer underwent surgery last week to remove a regrown tumour, but critical parts of the cancer could not be removed due to its location in the brain.
- He was the first patient to receive a pioneering immunotherapy treatment he co-developed, which extended his survival significantly beyond the initial prognosis of six to eight months.
- The experimental treatment has shown promising results in early studies and could pave the way for clinical trials aimed at improving outcomes for glioblastoma patients.
- Scolyer expressed gratitude for the extra time he has had with his family and hopes his work will benefit future patients, but he is now focusing on spending his remaining time with loved ones.